Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01211379 · ClinicalTrials.gov registry record · NA

The FLU-FOBT Program in Primary Care Settings Where Disparities Persist

A NA study of Colorectal Cancer, sponsored by University of California, San Francisco.

Completed
Registry status
NA
Development phase
1,372
Enrollment target
1
Study location

NCT01211379 is a NA study of Colorectal Cancer that has completed, run by University of California, San Francisco. The registered enrollment target is 1,372 participants, roughly in line with the 1,507-participant average among 369 other Colorectal Cancer trials with a reported enrollment target. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01211379, a NA study of Colorectal Cancer, has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
NA
Development phase
1,372 participants
Enrollment target
1
Study location

Study Summary

The investigators overall goals are to adapt, implement, evaluate, and disseminate the FLU-FOBT Program as an integrated nurse-run, primary care-based intervention that can reduce colorectal cancer screening disparities in resource-poor clinical settings. In this program, fecal occult blood tests (FOBT) are provided with influenza vaccinations (FLU) to eligible patients between the ages of 50 and 75 during FLU season. The investigators hypothesis is that the FLU-FOBT Program can be adapted for primary care settings and lead to higher rates of colorectal cancer screening (CRCS).

Conditions Studied

Interventions

  • BEHAVIORAL FLU-FOBT Program

Study Locations (1)

California

  • San Francisco Department of Public Health - San Francisco

Trial Details

FieldValue
Enrollment Target 1,372 participants
Start Date 2009-10
Est. Completion 2010-08
Phase NA

What the Registry Record Tells You About NCT01211379

The ClinicalTrials.gov registry entry for NCT01211379 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,372 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 1,507-participant average among 369 other Colorectal Cancer trials with a reported enrollment target. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Colorectal Cancer appearing as the primary indexed condition, and to 1 intervention - of which FLU-FOBT Program is the first listed.

NCT01211379 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT01211379 about?

NCT01211379 is a clinical study titled "The FLU-FOBT Program in Primary Care Settings Where Disparities Persist". The investigators overall goals are to adapt, implement, evaluate, and disseminate the FLU-FOBT Program as an integrated nurse-run, primary care-based intervention that can reduce colorectal cancer screening disparities in resource-poor clinical settings. In this program, fecal occult blood tests (F...

What is the current status of trial NCT01211379?

This trial is currently completed. It is a NA study. The enrollment target is 1,372 participants. The study started on 2009-10. Estimated completion is 2010-08.

What conditions does trial NCT01211379 study?

This clinical trial studies the following conditions: Colorectal Cancer.

What interventions are being tested in trial NCT01211379?

The interventions under investigation include: FLU-FOBT Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT01211379?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01211379 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Colorectal Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.